Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenesis induction is the physiological process involving the formation of new blood vessels from pre-existing vasculature. It is tightly regulated by a balance of pro-angiogenic and anti-angiogenic factors and plays critical roles in development, tissue repair, and disease. Aberrant angiogenesis is implicated in various pathologies, including cancer and ischemic diseases, making it an important therapeutic target.
Modulation of pro-angiogenic and anti-angiogenic factors, including VEGF, FGF, Angiopoietins, Angiostatin, and Endostatin. Targeting signaling pathways such as PI3K/AKT and MAPK.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis Induction.